Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on corporate actions taken during October 2023, with the report signed on November 9, 2023. The filing specifically addresses compliance with Article 11 of CVM Instruction # 358/2002 regarding transactions in the company's own securities.
Key Financial Metrics
The filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it details a share repurchase program executed in October 2023:
- Total Shares Repurchased: 3,000,000 Common Shares
- Total Volume Spent: R$ 39,265,086.00
- Price Range: R$ 12.90 to R$ 13.20 per share
- Intermediary: UBS
- Treasury Stock Balance: Increased from 10,858,139 to 13,858,139 shares
Material Changes
The primary material change reported is the increase in the company's treasury stock position. Ambev S.A. acquired 3,000,000 additional common shares, representing a significant reduction in outstanding shares available to the public and an injection of capital back into the company's equity structure.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, or specific risk factors. The document is strictly a regulatory disclosure of share acquisition transactions.
Investor Verification Checklist
- Verify the impact of the 3,000,000 share buyback on earnings per share (EPS) in the subsequent quarterly report.
- Confirm the total remaining authorization for the share acquisition plan, as this filing only covers October 2023 activity.
- Review the company's cash position to ensure the R$ 39.3 million outflow aligns with liquidity management strategies.
- Check for any subsequent filings regarding the retirement or re-issuance of these treasury shares.